Addressing Cancer Survivorship in Vulnerable Populations

Saturday, November 16, 2024

11:30 AM – 12:30 PM CT

Location: Texas Ballroom A

CE: 1.00 credits/hours

Speaker(s)

Rose DiMarco, PharmD, BCPS, BCOP (she/her/hers)

Oncology and Infusion Pharmacy Manager
Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Kelly Haviland, PhD, RN, FNP-BC, TGNB-C

Advanced Practice Provider Manager, Professional Development, Quality and LGBTQI+ Clinical Consultant
Memorial Sloan Kettering Cancer Center
Aileen Anglin, APRN, ACNP-BC, AOCNP®

Nurse Practitioner
The University of Texas MD Anderson Cancer Center
Spring, Texas, United States

Disclosures:

Rose DiMarco has acted as a consultant for Acclinate, Lilly, and Gilead, and served on the speaker's bureau for Lilly.
Kelly Haviland has acted as a consultant for Johnson & Johnson. Aileen Anglin has no relevant financial relationships to disclose.

Learning Objectives:

Review the current state of cancer disparities in survivorship, integrating insights from sources such as the AACR Disparities Progress Report
Discuss the management of long-term side effects of cancer treatment with a focus on vulnerable populations
Identify ways that advanced practitioners can provide comprehensive and equitable survivorship care to all patients with cancer